Receipt of financial assistance for oral targeted therapy among older adults with advanced non-small cell lung cancer: A prospective cohort study
Year: 2024
Type: article
Study design: Observational Study
Abstract: Older adults with cancer are at increased risk for financial toxicity given high rates of polypharmacy, out-of-pocket costs, fixed incomes, and financial management challenges [1]. Furthermore, older adults with cancer who experience financial toxicity are at increased risk for depression, anxiety, and decreased quality of life (QOL) [1,2]. Oral targeted therapies may compound financial toxicity due to high cost-sharing requirements under Medicare Part D, the prescription drug benefit that insures most older adults [3].
Source: Journal of Geriatric Oncology
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: hybrid
Estimated APC paid: $3,400
Awards: Expanding the Definition of Treatment Toxicity in Older Adults with Lung Cancer, G1750238285, California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations, Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussions, Institutional Career Development Core, Center for Aging in Diverse Communities: Ending Health Inequities in Older Adults, UCSF Older Americans Independence Center
OpenAlex ID: W4392859442